BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2001
View Archived Issues
Phase III comparative trial of PEG-Intron and Intron A for CML completed
Read More
Cephalon signs marketing and distribution agreement for Actiq in Australia and New Zealand
Read More
deCODE Genetics and Genmab enter RA alliance
Read More
New asthma therapy advances to clinical trials at Kyowa Hakko
Read More
Codevelopment agreement reached by Meiji Seika and Solvay for new PD agent
Read More
Adenovirus-mediated BMP-2 gene transfer effective in bone defect model
Read More
GlaxoSmithKline characterizes SAR for new series of NNRTIs
Read More
New biotechnology company formed -- Biovitrum
Read More
Intellivax receives funding from Technology Partnerships Canada for Proteosomes
Read More
NDA for Plenaxis denied FDA approval
Read More
Biomarkers for detecting amyloid aggregates in brain
Read More
Canadian launch announced for meningitis conjugate vaccine
Read More
AUA news: FimCH vaccine protects against challenge with invasive pyelonephritic E. coli
Read More
Xenova gains license to Viron's antiinflammatory protein
Read More
In vivo efficacy proven for Genmab's HuMax-EGFr
Read More
Intranasal apomorphine now in phase II testing in both male and female sexual dysfunction
Read More
Phase I evaluation of CAT-213 begins
Read More
Promising results emerge from Tularik-ChemoCentryx drug discovery initiative
Read More
Oral desmopressin may have role in nocturia according to AUA presentations
Read More
Ivax set to begin phase II study of GYKI-16084 for BPH
Read More
Broad-spectrum antibacterial agents from GSK act on FabH
Read More
Inhibitors of cathepsin S and/or L and their use described by AstraZeneca researchers
Read More
Hydroxamic acid-based inhibitors of sCD23 formation claimed in recent patent
Read More
High response rate and rapid and sustained responsiveness reported for Cialis in ED
Read More
Yamanouchi presents stable, orally active PDE4 inhibitors
Read More
Microcide and Cetek to discover new antimicrobials
Read More
New series of telomerase inhibitors identified by Kyowa Hakko
Read More
PDE4 inhibitors prepared at Byk Gulden may have therapeutic application in inflammation or ED
Read More